ProSomnus Sleep Technologies
ProSomnus Sleep Technologies designs and manufactures precision-engineered intraoral medical devices and the FDA-cleared RPMO2 theragnostic platform for obstructive sleep apnea treatment, sold direct to dental sleep medicine providers and reimbursed by commercial insurance, Medicare, and TRICARE across the US, Germany, and Switzerland.
- Company typePrivate
- Founded2016
- HeadquartersPleasanton, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What ProSomnus Sleep Technologies does
ProSomnus Sleep Technologies designs and manufactures precision-engineered intraoral medical devices for the treatment of obstructive sleep apnea (OSA), serving dental sleep medicine providers, sleep physicians, and OSA patients globally. The company's core technology is a 'Smart Sleep Medicine' platform that combines custom-fabricated oral appliances with embedded physiologic monitoring — most notably the FDA-cleared RPMO2 OSA Device, which is the first theragnostic device in sleep medicine to integrate oral appliance therapy with multi-night SpO2 and pulse rate measurement via an intraoral buccal mucosal oximeter, transmitting data through the Oxymetrx smartphone app and a HIPAA-compliant Provider Portal. Supporting the platform are the EVO family of devices (EVO, EVO Select, EVO Guided, EVO [PH]), the HWO2 buccal mucosal wellness oximeter, and the Morning Occlusal Guide (MOG), all protected by an IP portfolio of 11+ granted US patents, an EU patent validated in France/Germany/UK, and a pipeline of pending applications covering device architecture, iterative titration, and automated manufacturing.
The company operates a B2B2C go-to-market: ProSomnus sells direct to dentists and sleep medicine providers through a sales-led motion, supported by a provider portal, starter kits, CE courses, and clinical education, while end-patients are reached via provider prescription. Devices are reimbursed through commercial insurance, Medicare, TRICARE, and government-sponsored plans representing more than 200 million covered lives, with the company stating a 33% lower lifetime net device cost versus CPAP. Headquartered in Pleasanton, California, with regional offices in Munich and Oberentfelden (Switzerland), ProSomnus claims a network of thousands of providers globally and more than 100,000 cumulative users, generating revenue primarily from hardware sales supplemented by recurring remote patient monitoring services and warranty/replacement contracts.
The corporate history includes a December 2022 SPAC merger with Lakeshore Acquisition I Corp. (Nasdaq: OSA, ~$168M valuation), a voluntary Chapter 11 filing in August 2024 that reduced debt by approximately 60% and took the company private with $20M in new financing, and a subsequent $38M strategic investment from Catalio Capital Management in February 2026 to fund global expansion and next-generation RPM/diagnostic development. Ownership remains anchored by healthcare-focused private equity firm HealthpointCapital LLC, with other institutional backers including Spring Mountain Capital, Littlejohn & Co., and Masters Special Situations.
ProSomnus Sleep Technologies firmographics
Firmographics- Name
- ProSomnus Sleep Technologies
- Legal name
- ProSomnus Sleep Technologies, Inc.
- Website
- https://prosomnus.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- ProSomnus Sleep Technologies designs and manufactures precision-engineered intraoral medical devices and the FDA-cleared RPMO2 theragnostic platform for obstructive sleep apnea treatment, sold direct to dental sleep medicine providers and reimbursed by commercial insurance, Medicare, and TRICARE across the US, Germany, and Switzerland.
- Ownership category
- akta.pro rank
ProSomnus Sleep Technologies industry classification
Industry- Product category
- Sleep Apnea Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Dental Laboratories (339116), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Dental Equipment & Supplies (3843), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Sleep & Airway Orthodontics (OSA Appliances/Expansion) (HLABABAI)
- akta.pro secondary industries
- Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)
Keywords
Where ProSomnus Sleep Technologies is headquartered
LocationHeadquarters
- HQ city
- Pleasanton
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
ProSomnus Sleep Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Medical Device Sales: Sale of FDA-cleared intraoral medical devices for obstructive sleep apnea treatment. Devices are covered by commercial insurance, Medicare, and TRICARE, representing over 200 million covered lives globally. Revenue is generated through provider orders via portal.
- Remote Patient Monitoring Services: Connected care services through the RPMO2 platform enabling multi-night physiologic monitoring, with data transmitted to providers via smartphone application and provider portal.
- Warranty and Replacement Services: Device warranty policies and replacement services for oral appliances.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
ProSomnus Sleep Technologies product offering
Product offeringCore offering
ProSomnus Sleep Technologies designs, manufactures, and sells FDA-cleared precision intraoral medical devices for the treatment of obstructive sleep apnea (OSA) and snoring. The company sells directly to dentists, dental sleep medicine providers, and sleep physicians through its provider portal, with devices reimbursed by commercial insurance, Medicare, and TRICARE. The portfolio includes the EVO family of oral appliances (EVO, EVO Select, EVO Guided, EVO PH) and the RPMO2 OSA Device, which is the first FDA-cleared theragnostic device combining oral appliance therapy with multi-night physiologic monitoring.
Product overview
ProSomnus Sleep Technologies offers a portfolio of precision oral appliance therapy devices for obstructive sleep apnea (OSA) treatment, led by the EVO product line (EVO, EVO Select, EVO Guided, EVO PH) and the connected RPMO2 theragnostic platform. The portfolio also includes the HWO2 wellness oximeter and Morning Occlusal Guide. The EVO devices are custom-fabricated precision oral appliances FDA-cleared for OSA treatment, while RPMO2 integrates physiologic monitoring (SpO2, pulse rate) with therapy via embedded oximetry and companion app/portal. Supporting software includes the Oxymetrx patient app and provider portal for data access.
Differentiator
Problem solved
Functional benefit
Brands
- EVO: Precision oral appliance therapy device for obstructive sleep apnea treatment
- EVO Guided
- EVO Select
- EVO PH
- RPM02 OSA Device
- MOG (Morning Occlusal Guide)
- Smart Sleep Medicine
- HWO2
Products and services
- ProSomnus EVO Sleep and Snore Device FDA-cleared precision oral appliance providing patient-preferred OSA therapy as a non-CPAP alternative for treating obstructive sleep apnea and snoring, prescribed and fitted by dentists and dental sleep medicine providers.
- ProSomnus EVO Select Sleep and Snore Device Precision oral appliance engineered for performance, biocompatibility, and maximum patient comfort for the treatment of obstructive sleep apnea and snoring; custom-fabricated and FDA-cleared.
- ProSomnus EVO Guided Sleep and Snore Device First oral device bioengineered to dilate both the velopharynx and oropharynx, featuring a 95-degree guided prescription mechanism and anatomical splint design providing up to 14 times more tongue space, for obstructive sleep apnea and snoring treatment.
- ProSomnus EVO [PH] Sleep and Snore Device
- ProSomnus RPMO2 OSA Device First FDA-cleared theragnostic device for sleep medicine combining precision oral appliance therapy with multi-night physiologic monitoring in a single device; measures oxygen saturation (SpO2) and pulse rate via intraoral buccal mucosal oximeter with data transmitted to providers through the Oxymetrx smartphone app and provider portal.
- ProSomnus HWO2 Device Buccal mucosal wellness oximeter enabling patients to monitor nightly health and wellness during sleep, specifically blood oxygen saturation, pulse rate, and overall use time from smartphones.
Quantifiable outcome
- 96% patient satisfaction rate vs CPAP and traditional solutions
- +6 more outcomes
Companies that use ProSomnus Sleep Technologies
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles2 records
ProSomnus Sleep Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
ProSomnus Sleep Technologies partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MonitAircoreCollaboration to integrate ProSomnus's FDA-cleared RPMO2 OSA Device with MonitAir's remote patient monitoring platform for managing obstructive sleep apnea patients. The integration enables continuous, multi-night physiologic data monitoring and supports care coordination across clinical workflows through MonitAir's HIPAA-compliant platform that aggregates remote physiologic monitoring, remote therapeutic monitoring, and chronic care management capabilities.
Scale indicators10 records
Recent moves8 records
Expansion highlights6 records
ProSomnus Sleep Technologies competitors and assessment
Company assessmentDirect peers
- SomnoMed: Global leader in mandibular advancement devices for OSA, offering competing oral appliances (SomnoDent) sold through dentists and sleep physicians. Closest direct competitor to ProSomnus's EVO line in the OAT category with similar provider channel and insurance reimbursement model.
- Vivos Therapeutics: Developer of the Vivos System, a dental appliance-based treatment for mild-to-moderate OSA targeting dental sleep medicine providers. Competes directly with ProSomnus for the same dental sleep channel and OSA patient population.
- Panthera Dental: Manufacturer of CAD/CAM-milled mandibular advancement devices (Panthera D-SAD) for sleep apnea. Direct competitor in the precision-engineered OAT segment with comparable dentist-channel distribution and clinical positioning.
- Airway Management: Developer of the TAP (Thornton Adjustable Positioner) oral appliances for OSA and snoring. Established direct competitor in the dental sleep medicine market targeting similar patient and provider segments as ProSomnus.
Broad incumbents
- ResMed: Dominant global player in sleep-disordered breathing with CPAP/APAP devices and growing OAT portfolio (acquired Whole You). Represents the largest incumbent competitor and a broad market leader across OSA treatment modalities.
- Philips Respironics: Major incumbent offering CPAP devices and competing OSA solutions. Despite ongoing recall-related headwinds, remains a significant force in sleep apnea treatment and competes for payer attention and provider mindshare.
- Inspire Medical Systems: Public medtech company commercializing hypoglossal nerve stimulation (Inspire UAS) as a surgical alternative for moderate-to-severe OSA. Competes for the same severe-OSA patient pool and sleep physician referrals as ProSomnus.
Regional players
- Oventus Medical: Australia-based developer of O2Vent oral appliances for OSA, focused primarily on the APAC region. Comparable precision-engineered OAT offering with differentiated airway channel design, though serving a different geographic market than ProSomnus's US/EU core.
Others
- Itamar Medical (ZOLL/ResMed): Sleep diagnostics platform (WatchPAT) for home sleep testing, now part of ZOLL/ResMed. Adjacent ecosystem player providing OSA diagnosis that drives downstream OAT/CPAP prescribing, complementary to ProSomnus's therapy positioning.
- Natus Medical: Provider of neurodiagnostic and sleep diagnostic equipment including PSG systems used in sleep labs. Enabling player in the OSA value chain that complements ProSomnus's therapy devices with the diagnostic infrastructure that generates referrals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
ProSomnus Sleep Technologies social profiles
Digital presenceProSomnus Sleep Technologies compliance and trust
Trust signalCompliance3 records
ProSomnus Sleep Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProSomnus Sleep Technologies leadership team
Management profileNumber of profiles
Profiles17 records
ProSomnus Sleep Technologies subsidiaries and ownership
Company hierarchySubsidiaries2 records
ProSomnus Sleep Technologies funding detail
Funding detailFunding overview
Funding rounds6 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProSomnus Sleep Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProSomnus Sleep Technologies
What does ProSomnus Sleep Technologies do?
ProSomnus Sleep Technologies designs, manufactures, and sells FDA-cleared precision intraoral medical devices for the treatment of obstructive sleep apnea (OSA) and snoring. The company sells directly to dentists, dental sleep medicine providers, and sleep physicians through its provider portal, with devices reimbursed by commercial insurance, Medicare, and TRICARE. The portfolio includes the EVO family of oral appliances (EVO, EVO Select, EVO Guided, EVO PH) and the RPMO2 OSA Device, which is the first FDA-cleared theragnostic device combining oral appliance therapy with multi-night physiologic monitoring.
Is ProSomnus Sleep Technologies a public or private company?
ProSomnus Sleep Technologies is a private company. It is classified as private equity controlled and is currently operating.
When was ProSomnus Sleep Technologies founded?
ProSomnus Sleep Technologies was founded in 2016. It employs 101 to 250 people.
Where is ProSomnus Sleep Technologies based?
ProSomnus Sleep Technologies is headquartered in Pleasanton, United States, in the North America region.
How does ProSomnus Sleep Technologies make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are remote Patient Monitoring Services and warranty and Replacement Services.
Who are ProSomnus Sleep Technologies's main competitors?
Direct peers on record are SomnoMed, Vivos Therapeutics, Panthera Dental and Airway Management. Broad incumbents are ResMed, Philips Respironics and Inspire Medical Systems. Oventus Medical is listed as a regional player. Others are Itamar Medical (ZOLL/ResMed) and Natus Medical.
Does ProSomnus Sleep Technologies have an API?
No public API is recorded for ProSomnus Sleep Technologies.
What industry is ProSomnus Sleep Technologies in?
ProSomnus Sleep Technologies's product category is Sleep Apnea Medical Devices. Its primary akta.pro industry code is HLABABAI, Sleep & Airway Orthodontics (OSA Appliances/Expansion), with a secondary code of HLAHAGAB, Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy). Its NAICS code is 339113 and its SIC code is 3842.